A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Turning Point Therapeutics, Inc.
Turning Point Therapeutics, Inc.
Altor BioScience
Amgen
iOMEDICO AG
Celgene
InSightec
Amgen
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Bellus Health Inc. - a GSK company